Toxicology of Organophosphate &Amp; Carbamate Compounds 2006
DOI: 10.1016/b978-012088523-7/50015-6
|View full text |Cite
|
Sign up to set email alerts
|

Methods for Measuring Cholinesterase Activities in Human Blood

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
7
0

Year Published

2012
2012
2022
2022

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 32 publications
0
7
0
Order By: Relevance
“…This lack of sensitivity, when a population baseline is used to detect inhibition, is partially due to the normal interindividual enzyme activity variation, which is about 15–25% for BChE and 10–18% for AChE, and the intraindividual variation over time, which ranges between 6 and 3–7%, respectively [ 42 ]. Hence, an individual ChE activity baseline is necessary [ 21 , 24 , 43 , 44 ].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…This lack of sensitivity, when a population baseline is used to detect inhibition, is partially due to the normal interindividual enzyme activity variation, which is about 15–25% for BChE and 10–18% for AChE, and the intraindividual variation over time, which ranges between 6 and 3–7%, respectively [ 42 ]. Hence, an individual ChE activity baseline is necessary [ 21 , 24 , 43 , 44 ].…”
Section: Discussionmentioning
confidence: 99%
“…The lower sensitivity of BChE inhibition as a biomarker of exposure to OPs and CAR can be explained by the higher turnover of this enzyme when compared to AChE, for which the recovery of the activity is limited by the production of new erythrocytes, which takes over 120 days [ 22 ]. Thus, AChE remains depressed for a longer period [ 43 , 44 ]. In this study, all 10 farmers with enzyme depletion rates higher the cut off levels were from Taquara.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Unfortunately, none of the currently used oximes is sufficiently effective against all inhibitors and there is no single reactivator having the ability to reactivate inhibited enzyme regardless of the chemical structure of the inhibitor [7,8]. Commonly used reactivators are characterised by the presence of several structural features: functional oxime group, quaternary nitrogen atom and different length of linking chain between two pyridinium rings in the case of bispyridinium reactivators [9,10]. Pyridoxal oxime, a derivative of B 6 vitamin, meets some of these structural features and can be used for synthesis of compounds structurally similar to common antidotes.…”
Section: Introductionmentioning
confidence: 99%
“…However, ICD-467 was ineffective in reactivating AChE in the brain and was found to be toxic (Shih, 1993;Harris et al, 1990). Imidazolium oximes can reactivate tabun-inhibited AChE (an adduct which contains a P-N bond instead of a P-O bond), and some can reactivate both tabun-inhibited and somaninhibited AChE (RS150D, 70% reactivation of GA; Im2-2, 44% reactivation of GA; Im2-13, 20% reactivation of GA and 71% reactivation of GD; Kovarik et al, 2013;Reiner & Simeon-Rudolf, 2006;Primožič et al, 2004). None have been superior to the bispyridinium oximes in reactivating tabuninhibited AChE (TMB-4, 91% reactivation of GA; obidoxime, 88% reactivation of GA; Worek et al, 2012); however, TMB-4 is ineffective against GD (Inns & Leadbeater, 1983) and obidoxime is also a poor reactivator of GD-inhibited AChE (Worek et al, 1998).…”
Section: Discussionmentioning
confidence: 99%